March 31, 2017
A New Jersey federal judge on Friday dismissed patent litigation between Tyco Healthcare Group LP and Mutual Pharmaceutical Co. Inc. over the sleep aid Restoril after the two reached a settlement, ending the decade-long litigation, which had also involved failed antitrust counterclaims.
June 01, 2015
A New Jersey federal judge found that Tyco Healthcare Group LP's patent suit over Mutual Pharmaceutical Company Inc.'s generic version of Restoril wasn't a sham, rejecting Mutual's antitrust counterclaim Friday after the Federal Circuit remanded the case for a second look at the allegations.
March 28, 2007
Tyco Healthcare Group LP has filed a lawsuit against a subsidiary of Pharmaceutical Holdings Corp., alleging it infringed four patents for Restoril by seeking approval to make a generic version of the sleep aid.